Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: cardiologist to be who wrote (1083)	3/9/1998 9:40:00 PM
From: margaret foley	Read Replies (2) \| Respond to of 1359

I wonder how far away from becoming a cardiologist are you? Good to see IPIC up, albeit a bit! All the best, Margaret

To: cardiologist to be who wrote (1083)	3/16/1998 10:44:00 AM
From: KurtVedder	Read Replies (1) \| Respond to of 1359

FWIW I spoke with one of the cardiologist's in my family regarding the studies that are being conducted in his hospital (Tulane)-he stated that there has been NO abnormalities in the Redux patients as of yet. They are considering stopping the study due to the fact that they feel it is a "waste of time". In addition, he claims he heard info regarding the Harvard study that has, in his words, leaked out. He says the studies show, in his words, "NOTHING". He told me to relax. He feels that info will come out at the big ACC (Cardiology) conference in Atlanta at the end of March. He tells me that the general consensus among cardiologist's is that this is way overblown. We shall see. Take it all with a grain of salt, but I believe that buying IPIC is a good bet.